Vitamin A derivative provides clues to better breast cancer drugs

Retinoic acid, a derivative of vitamin A, could lead researchers to a new set of drug targets for treating breast cancer, researchers from the University of Chicago report in the June 25, 2009, issue of the journal Cell.

If you want to include this story in your blog, copy and paste this formatted text:

<p><a href="http://www.physorg.com/news165152817.html">Vitamin A derivative provides clues to better breast cancer drugs</a></p> <p>Retinoic acid, a derivative of vitamin A, could lead researchers to a new set of drug targets for treating breast cancer, researchers from the University of Chicago report in the June 25, 2009, issue of the journal <i>Cell</i>.</p>